Über uns
•Over 10+ years of Experience in Firmware/Software Engineering for design and development…
Activity
-
Press Release: Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for CellFX® nsPFA Cardiac Surgery System for the…
Press Release: Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for CellFX® nsPFA Cardiac Surgery System for the…
Liked by Chirayu Shah
-
Leadership isn't about commanding; it's about serving. Servant leadership puts people first. This philosophy, popularized by Robert K. Greenleaf…
Leadership isn't about commanding; it's about serving. Servant leadership puts people first. This philosophy, popularized by Robert K. Greenleaf…
Liked by Chirayu Shah
-
From surgical to catheter-based therapies, our Nanosecond Pulsed Field Ablation (nsPFA™) platform is designed to provide a foundation for diverse…
From surgical to catheter-based therapies, our Nanosecond Pulsed Field Ablation (nsPFA™) platform is designed to provide a foundation for diverse…
Liked by Chirayu Shah
Bildung
More activity by Chirayu
-
Team USA made it big at the cricket World Cup today. It seemed only natural that an immigrant Indian Engineer from the Silicon Valley played an…
Team USA made it big at the cricket World Cup today. It seemed only natural that an immigrant Indian Engineer from the Silicon Valley played an…
Liked by Chirayu Shah
-
🌟 Breaking New Ground in Healthcare 🌟 I am honored to announce that I am among the first group of physicians globally to utilize the revolutionary…
🌟 Breaking New Ground in Healthcare 🌟 I am honored to announce that I am among the first group of physicians globally to utilize the revolutionary…
Liked by Chirayu Shah
-
Talk about a stock bump. Shares of biotech firm Summit Therapeutics more than tripled on Thursday following good news about a drug candidate to treat…
Talk about a stock bump. Shares of biotech firm Summit Therapeutics more than tripled on Thursday following good news about a drug candidate to treat…
Liked by Chirayu Shah
-
We’re on a mission to improve patient care through safe, nonthermal minimally invasive procedures. See how our now FDA-cleared CellFX® Nanosecond…
We’re on a mission to improve patient care through safe, nonthermal minimally invasive procedures. See how our now FDA-cleared CellFX® Nanosecond…
Liked by Chirayu Shah
-
“I am very proud and excited that the first U.S. patient treatment with soft tissue ablation by the CellFX nsPFA system was performed this week in…
“I am very proud and excited that the first U.S. patient treatment with soft tissue ablation by the CellFX nsPFA system was performed this week in…
Liked by Chirayu Shah
-
Stay on the pulse of Endocrine Surgery at #AAES2024. Join us to hear why surgeons like Dr. Kepal Patel are excited to use the now FDA-cleared…
Stay on the pulse of Endocrine Surgery at #AAES2024. Join us to hear why surgeons like Dr. Kepal Patel are excited to use the now FDA-cleared…
Liked by Chirayu Shah
-
The CellFX® nsPFA™ Percutaneous Electrode System is the first and only device to utilize nonthermal, natural, and precise Regulated Cell Death as the…
The CellFX® nsPFA™ Percutaneous Electrode System is the first and only device to utilize nonthermal, natural, and precise Regulated Cell Death as the…
Liked by Chirayu Shah
-
📢Pulse Biosciences, Inc. secures FDA approval for CellFX nsPFA system CellFX is a percutaneous electrode system intended for use in the ablation of…
📢Pulse Biosciences, Inc. secures FDA approval for CellFX nsPFA system CellFX is a percutaneous electrode system intended for use in the ablation of…
Liked by Chirayu Shah
-
Curious minds are easier to find when inclusion is a normal part of our business. Happy #InternationalWomensDay to the phenomenal women helping…
Curious minds are easier to find when inclusion is a normal part of our business. Happy #InternationalWomensDay to the phenomenal women helping…
Liked by Chirayu Shah
-
We raised our maiden round of funding! Thank you to all our customers for investing in us all these years. You will always remain our first…
We raised our maiden round of funding! Thank you to all our customers for investing in us all these years. You will always remain our first…
Liked by Chirayu Shah
-
PRESS RELEASE: Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for the Initial Patients treated in the CellFX® nsPFA™ 360 Cardiac…
PRESS RELEASE: Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for the Initial Patients treated in the CellFX® nsPFA™ 360 Cardiac…
Liked by Chirayu Shah
Other similar profiles
Gemeinsame Artikel erkunden
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Chirayu Shah in United States
-
Chirayu Shah
-
Chirayu Shah
-
Chirayu Shah
"Empowering Talent, Driving Success: Your Partner in Recruitment Excellence." Experinced in AI with MS Excel and PowerBI
-
Chirayu Shah
29 others named Chirayu Shah in United States are on LinkedIn
See others named Chirayu Shah